Ads
related to: cprx stock- Markets & Economy
View Our Latest Market Insights
and Get Economic Forecasts.
- PracticeLab®
Resources to Help You Build Your
Business and Engage Your Clients.
- Market Volatility
Insights on Current Conditions from
Our Investment Professionals.
- Subscribe to Newsletter
Receive Our Latest Investment
Thinking In Your Inbox Each Week.
- Capital Ideas Webinars
Our Brightest Minds Answer
Your Questions.
- Equity Insights
View Our Latest Equity
Investment Insights.
- Markets & Economy
Search results
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 hours agoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Catalyst...
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks via Yahoo Finance· 1 day agoQuote Regulatory Update In October 2023, the FDA accepted CPRX’s supplemental new drug application...
Q&A: This New CEO Has Big Ideas For A Small Biotech
Investor's Business Daily· 10 hours agoCatalyst Pharmaceuticals' (CPRX) new Chief Executive, Richard Daly, is no stranger to working at big companies. Catalyst is not a pharma giant. Former...
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates
Zacks· 5 days agoFree Report) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.55. This quarterly report represents an earnings surprise of -7.27%. Over the ...
Top 10% Biotech Doubles Profit Views; Shares Jump
Investor's Business Daily· 2 days agoThe company doubled Wall Street's earnings views, but sales came in short.
Catalyst: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 2 days agoThe specialty drug company posted revenue of $98.5 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $97.2 million. _____ This story was generated ...
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 4 days agoANIP beat on earnings in each of the trailing four quarters, delivering an average surprise of...
ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
Zacks via Yahoo Finance· 4 days agoANI Pharmaceuticals' (ANIP) revenues in the first quarter of 2024 are likely to have been driven by...
Recursion (RXRX) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 4 days agoRecursion (RXRX) is expected to provide updates on its oncology and rare disease clinical-stage...
